Fundraising

Fundraising
€3.0 M

Healthcare

Date

June 2026

Client(s)

Counterpart(s)

Country

Rodolphe Ossola

Managing Partner

+33 (0)6 03 40 58 37

rodolphe.ossola@atoutcapital.com

Fundraising

Fundraising
€3.0 M

SteriFrance is a French laboratory specializing in the development, manufacturing and distribution of hygiene and disinfection solutions for healthcare institutions, healthcare professionals and the professional hygiene sector.

Headquartered in Le Perray-en-Yvelines, France, where its manufacturing facility and R&D center are located, the Group offers a comprehensive range of medical device disinfection products, surface and floor treatment solutions, hand hygiene products, as well as complementary solutions for hospital and industrial environments. SteriFrance serves an exclusively B2B customer base comprising hospitals, clinics, healthcare professionals, public facilities, industrial companies and laboratories.

The Group currently operates in more than 50 countries and benefits from a fully integrated business model covering the entire value chain, including formulation, manufacturing, regulatory affairs, quality management, and technical and scientific support. Supported by strong market fundamentals and increasingly stringent health and regulatory requirements, SteriFrance has achieved annual growth in excess of 20% over the past three years.

ATOUT CAPITAL acted as financial advisor to SteriFrance in connection with a €3 million fundraising completed with ODYSSEE VENTURE. Structured through a combination of equity and quasi-equity instruments, the transaction enables Nicolas VARAY and Julien CHARRAT, SteriFrance’s managing shareholders, to retain control of the Group while providing the financial resources required to support its continued development.

The proceeds of the transaction will enable SteriFrance to further strengthen its organization, increase its investments in research and development and regulatory compliance, and support the ramp-up of its new industrial facility, which has benefited from significant investments over the past 24 months. The fundraising will also provide the Group with the financial flexibility required to actively pursue value-accretive M&A opportunities in line with its development strategy, with the objective of strengthening its market positions, broadening its portfolio of activities and accelerating its expansion both in France and internationally.